1. |
Braganza JM, Lee SH, McCloy RF, et al. Chronic pancreatitis. Lancet, 2011, 377(9772): 1184-1197.
|
2. |
《中华胰腺病杂志》编委会. 中国胰腺外分泌功能不全诊治规范 (草案). 中华胰腺病杂志, 2013, 13(1): 45-48.
|
3. |
Keller J, Aghdassi AA, Lerch MM, et al. Tests of pancreatic exocrine function—clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol, 2009, 23(3): 425-439.
|
4. |
DiMagno EP, Malagelada JR, Go VL. Relationship between alcoholism and pancreatic insufficiency. Ann N Y Acad Sci, 1975, 252: 200-207.
|
5. |
Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut, 2005, 54(Suppl 6): v1-v28.
|
6. |
Carrière F, Laugier R, Barrowman JA, et al. Gastric and pancreatic lipase levels during a test meal in dogs. Scand J Gastroenterol, 1993, 28(5): 443-454.
|
7. |
Layer P, Go VL, DiMagno EP. Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol, 1986, 251(4 Pt 1): G475-G480.
|
8. |
Nakamura T, Takeuchi T, Tando Y. Pancreatic dysfunction and treatment options. Pancreas, 1998, 16(3): 329-336.
|
9. |
Dutta SK, Bustin MP, Russell RM, et al. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med, 1982, 97(4): 549-552.
|
10. |
Johnson EJ, Krasinski SD, Howard LJ, et al. Evaluation of vitamin A absorption by using oil-soluble and water-miscible vitamin A preparations in normal adults and in patients with gastrointestinal disease. Am J Clin Nutr, 1992, 55(4): 857-864.
|
11. |
Nakamura T, Takebe K, Imamura K, et al. Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency). Acta Gastroenterol Belg, 1996, 59(1): 10-14.
|
12. |
Teichmann J, Mann ST, Stracke H, et al. Alterations of vitamin D3 metabolism in young women with various grades of chronic pancreatitis. Eur J Med Res, 2007, 12(8): 347-350.
|
13. |
Dujsikova H, Dite P, Tomandl J, et al. Occurrence of metabolic osteopathy in patients with chronic pancreatitis. Pancreatology, 2008, 8(6): 583-586.
|
14. |
Hart PA, Bellin MD, Andersen DK, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol, 2016, 1(3): 226-237.
|
15. |
王瑞星, 吴万春. 继发于慢性胰腺炎的 3c 型糖尿病的诊断与治疗. 国际消化病杂志, 2015, 35(1): 39-41.
|
16. |
Lin YK, Johnston PC, Arce K, et al. Chronic pancreatitis and diabetes mellitus. Curr Treat Options Gastroenterol, 2015, 13(3): 319-331.
|
17. |
Schrader H, Menge BA, Schneider S, et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology, 2009, 136(2): 513-522.
|
18. |
Andersen DK. Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas, 2007, 35(1): 1-15.
|
19. |
Hennig R, Kekis PB, Friess H, et al. Pancreatic polypeptide in pancreatitis. Peptides, 2002, 23(2): 331-338.
|
20. |
Śliwińska-Mossoń M, Milnerowicz H. Distribution of pancreatic polypeptide-secreting endocrine cells in nondiabetic and diabetic cases. Appl Immunohistochem Mol Morphol, 2017, 25(6): 422-431.
|
21. |
Meier JJ, Giese A. Diabetes associated with pancreatic diseases. Curr Opin Gastroenterol, 2015, 31(5): 400-406.
|
22. |
Gómez-Cerezo J, Garcés MC, Codoceo R, et al. Postprandial glucose-dependent insulinotropic polypeptide and insulin responses in patients with chronic pancreatitis with and without secondary diabetes. Regul Pept, 1996, 67(3): 201-205.
|
23. |
Waljee AK, Dimagno MJ, Wu BU, et al. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. Aliment Pharmacol Ther, 2009, 29(3): 235-246.
|
24. |
Taylor JR, Gardner TB, Waljee AK, et al. Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency. Aliment Pharmacol Ther, 2010, 31(1): 57-72.
|
25. |
Layer P, Keller J. Lipase supplementation therapy: standards, alternatives, and perspectives. Pancreas, 2003, 26(1): 1-7.
|
26. |
Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, et al. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol, 2007, 5(4): 484-488.
|
27. |
Safdi M, Bekal PK, Martin S, et al. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas, 2006, 33(2): 156-162.
|
28. |
Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol, 2010, 105(10): 2276-2286.
|
29. |
Domínguez-Muñoz JE, Iglesias-García J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? JOP, 2010, 11(2): 158-162.
|
30. |
Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M, et al. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut, 2006, 55(7): 1056-1057.
|
31. |
de la Iglesia-García D, Huang W, Szatmary P, et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut, 2017, 66(8): 1354-1355.
|
32. |
Witt H, Apte MV, Keim V, et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology, 2007, 132(4): 1557-1573.
|
33. |
Rodbard D. Continuous glucose monitoring: A review of successes, challenges, and opportunities. Diabetes Technol Ther, 2016, 18(Suppl 2): S3-S13.
|
34. |
Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg, 2001, 25(4): 452-460.
|
35. |
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2009, 32(1): 193-203.
|
36. |
Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract, 2009, 15(6): 540-559.
|
37. |
Drucker DJ, Sherman SI, Gorelick FS, et al. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care, 2010, 33(2): 428-433.
|
38. |
Malka D, Hammel P, Sauvanet A, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology, 2000, 119(5): 1324-1332.
|
39. |
Rebours V, Boutron-Ruault MC, Schnee M, et al. The natural history of hereditary pancreatitis: a national series. Gut, 2009, 58(1): 97-103.
|
40. |
Scheuing N, Berger G, Bergis D, et al. Adherence to clinical care guidelines for cystic fibrosis-related diabetes in 659 German/Austrian patients. J Cyst Fibros, 2014, 13(6): 730-736.
|
41. |
Knop FK, Vilsbøll T, Larsen S, et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab, 2007, 292(1): E324-E330.
|
42. |
O’Keefe SJ, Cariem AK, Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol, 2001, 32(4): 319-323.
|
43. |
Bellin MD, Freeman ML, Gelrud A, et al. Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest. Pancreatology, 2014, 14(1): 27-35.
|
44. |
Basevi V, Di Mario S, Morciano C, et al. Comment on: American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34(Suppl. 1): S11-S61. Diabetes Care, 2011, 34(5): e53.
|
45. |
Iván G. The principles of the treatment of pancreatic diabetes. Orv Hetil, 2009, 150(6): 273-276.
|